BNIP2_HUMAN - dbPTM
BNIP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BNIP2_HUMAN
UniProt AC Q12982
Protein Name BCL2/adenovirus E1B 19 kDa protein-interacting protein 2
Gene Name BNIP2
Organism Homo sapiens (Human).
Sequence Length 314
Subcellular Localization Cytoplasm. Cytoplasm, perinuclear region. Localizes to the nuclear envelope region and to other cytoplasmic structures.
Protein Description Implicated in the suppression of cell death. Interacts with the BCL-2 and adenovirus E1B 19 kDa proteins..
Protein Sequence MEGVELKEEWQDEDFPIPLPEDDSIEADILAITGPEDQPGSLEVNGNKVRKKLMAPDISLTLDPSDGSVLSDDLDESGEIDLDGLDTPSENSNEFEWEDDLPKPKTTEVIRKGSITEYTAAEEKEDGRRWRMFRIGEQDHRVDMKAIEPYKKVISHGGYYGDGLNAIVVFAVCFMPESSQPNYRYLMDNLFKYVIGTLELLVAENYMIVYLNGATTRRKMPSLGWLRKCYQQIDRRLRKNLKSLIIVHPSWFIRTLLAVTRPFISSKFSQKIRYVFNLAELAELVPMEYVGIPECIKQVDQELNGKQDEPKNEQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
41PhosphorylationGPEDQPGSLEVNGNK
CCCCCCCCEEECCHH
28.2124275569
47 (in isoform 2)Phosphorylation-34.1522210691
59PhosphorylationKLMAPDISLTLDPSD
EEECCCEEEEECCCC
23.7622468782
65PhosphorylationISLTLDPSDGSVLSD
EEEEECCCCCCCCCC
55.0322468782
71PhosphorylationPSDGSVLSDDLDESG
CCCCCCCCCCCCCCC
27.2422468782
77PhosphorylationLSDDLDESGEIDLDG
CCCCCCCCCCCCCCC
41.2024275569
85PhosphorylationGEIDLDGLDTPSENS
CCCCCCCCCCCCCCC
7.0924719451
87PhosphorylationIDLDGLDTPSENSNE
CCCCCCCCCCCCCCC
33.4824275569
89PhosphorylationLDGLDTPSENSNEFE
CCCCCCCCCCCCCCC
52.0524275569
92PhosphorylationLDTPSENSNEFEWED
CCCCCCCCCCCCCCC
33.4124275569
101PhosphorylationEFEWEDDLPKPKTTE
CCCCCCCCCCCCCCE
10.1927251275
106PhosphorylationDDLPKPKTTEVIRKG
CCCCCCCCCEEEECC
36.3926074081
107PhosphorylationDLPKPKTTEVIRKGS
CCCCCCCCEEEECCC
34.0926074081
109PhosphorylationPKPKTTEVIRKGSIT
CCCCCCEEEECCCCC
4.8827642862
114PhosphorylationTEVIRKGSITEYTAA
CEEEECCCCCEEEEE
29.4029255136
116PhosphorylationVIRKGSITEYTAAEE
EEECCCCCEEEEEEE
25.3322167270
118PhosphorylationRKGSITEYTAAEEKE
ECCCCCEEEEEEECC
7.9530278072
119PhosphorylationKGSITEYTAAEEKED
CCCCCEEEEEEECCC
17.1023927012
145UbiquitinationQDHRVDMKAIEPYKK
CCCCCCHHHCCCCCC
41.57-
162PhosphorylationSHGGYYGDGLNAIVV
HCCCCCCCCHHHEEE
42.14-
174 (in isoform 2)Ubiquitination-8.01-
185PhosphorylationSSQPNYRYLMDNLFK
CCCCCHHHHHHHHHH
8.9524667141
186 (in isoform 2)Ubiquitination-2.28-
198PhosphorylationFKYVIGTLELLVAEN
HHHHHHHHHHHHCCC
3.53-
207 (in isoform 2)Ubiquitination-2.23-
208PhosphorylationLVAENYMIVYLNGAT
HHCCCEEEEEECCCC
0.99-
210PhosphorylationAENYMIVYLNGATTR
CCCEEEEEECCCCCC
5.41-
213PhosphorylationYMIVYLNGATTRRKM
EEEEEECCCCCCCCC
23.00-
214 (in isoform 2)Ubiquitination-12.53-
228UbiquitinationPSLGWLRKCYQQIDR
CCHHHHHHHHHHHHH
34.81-
230PhosphorylationLGWLRKCYQQIDRRL
HHHHHHHHHHHHHHH
13.39-
233UbiquitinationLRKCYQQIDRRLRKN
HHHHHHHHHHHHHHH
2.34-
235PhosphorylationKCYQQIDRRLRKNLK
HHHHHHHHHHHHHHH
40.9620166139
237PhosphorylationYQQIDRRLRKNLKSL
HHHHHHHHHHHHHHE
10.7418088087
239PhosphorylationQIDRRLRKNLKSLII
HHHHHHHHHHHHEEE
71.8227642862
240PhosphorylationIDRRLRKNLKSLIIV
HHHHHHHHHHHEEEE
46.3919651622
245UbiquitinationRKNLKSLIIVHPSWF
HHHHHHEEEECHHHH
3.89-
266UbiquitinationVTRPFISSKFSQKIR
HHHHHHCHHHHHHHH
32.67-
267UbiquitinationTRPFISSKFSQKIRY
HHHHHCHHHHHHHHH
42.0921890473
281 (in isoform 2)Ubiquitination-3.59-
290 (in isoform 2)Ubiquitination-3.41-
306PhosphorylationVDQELNGKQDEPKNE
HHHHHCCCCCCCCCC
54.20-
329Ubiquitination----------------------
----------------------
21890473
329 (in isoform 2)Ubiquitination--
333 (in isoform 2)Ubiquitination--
340Ubiquitination---------------------------------
---------------------------------
-
349Ubiquitination------------------------------------------
------------------------------------------
-
368 (in isoform 2)Ubiquitination--
388Ubiquitination---------------------------------------------------------------------------------
---------------------------------------------------------------------------------
-
427Ubiquitination------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of BNIP2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BNIP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BNIP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BCL2_HUMANBCL2physical
12901880
CREB3_HUMANCREB3physical
16189514
CDC42_HUMANCDC42physical
10799524
BNIP2_HUMANBNIP2physical
10954711
CDC42_HUMANCDC42physical
10954711
RHG01_HUMANARHGAP1physical
10954711
RHG01_HUMANARHGAP1physical
10551883
FRK_HUMANFRKphysical
25416956
KLC1_HUMANKLC1physical
25416956
MYO5B_HUMANMYO5Bphysical
25416956
UPK1B_HUMANUPK1Bphysical
25416956
FATE1_HUMANFATE1physical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BNIP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114 AND THR-116, ANDMASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY.

TOP